Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Hsu

Showing results (311-320 of 361) with videos related to

Pageof 37
Sort By:
Scientific Reports|June 30, 2015
Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identificationYi-Yu Ke, Vivek Kumar Singh, Mohane Selvaraj Coumar, et al.
Critical Care (London, England)|June 29, 2011
CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency departmentW Frank Peacock, Joseph Varon, Brigitte M Baumann, et al.
Analytical Biochemistry|January 15, 2008
A mammalian cell-based reverse two-hybrid system for functional analysis of 3C viral protease of human enterovirus 71Jin-Ching Lee, Shin-Ru Shih, Ten-Yuan Chang, et al.
European Journal of Medicinal Chemistry|June 25, 2014
Ligand efficiency based approach for efficient virtual screening of compound librariesYi-Yu Ke, Mohane Selvaraj Coumar, Hui-Yi Shiao, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
PD-1 prelimits both the cytotoxic and exhaustion potential in thymic CD8+ T cells and impacts the maintenance of peripheral tumor immunityZhiming Mao, Jacob B Hirdler, Joanina K Gicobi, et al.
Journal for Immunotherapy of Cancer|October 28, 2025
Targeting PD-L1-CMTM6 interactions in myeloid cells triggers PD-L1 degradation and enhances cytotoxic T-cell expansionMichelle A Hsu, Xin Liu, Whitney Barham, et al.
Scientific Reports|June 17, 2015
Anchor-based classification and type-C inhibitors for tyrosine kinasesKai-Cheng Hsu, Tzu-Ying Sung, Chih-Ta Lin, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavirD J Kempf, K C Marsh, G Kumar, et al.
Plos One|November 13, 2024
Correction: Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase InhibitorsKai-Cheng Hsu, Hui-Chen Hung, Jim-Tong Horng, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2004
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamideChang-Jer Wu, Jia-Tsrong Jan, Chi-Min Chen, et al.
Pageof 37

Showing results (311-320 of 361) with videos related to

Sort By:
Pageof 37
Scientific Reports|June 30, 2015
Homology modeling of DFG-in FMS-like tyrosine kinase 3 (FLT3) and structure-based virtual screening for inhibitor identificationYi-Yu Ke, Vivek Kumar Singh, Mohane Selvaraj Coumar, et al.
Critical Care (London, England)|June 29, 2011
CLUE: a randomized comparative effectiveness trial of IV nicardipine versus labetalol use in the emergency departmentW Frank Peacock, Joseph Varon, Brigitte M Baumann, et al.
Analytical Biochemistry|January 15, 2008
A mammalian cell-based reverse two-hybrid system for functional analysis of 3C viral protease of human enterovirus 71Jin-Ching Lee, Shin-Ru Shih, Ten-Yuan Chang, et al.
European Journal of Medicinal Chemistry|June 25, 2014
Ligand efficiency based approach for efficient virtual screening of compound librariesYi-Yu Ke, Mohane Selvaraj Coumar, Hui-Yi Shiao, et al.
Biorxiv : the Preprint Server for Biology|January 27, 2025
PD-1 prelimits both the cytotoxic and exhaustion potential in thymic CD8+ T cells and impacts the maintenance of peripheral tumor immunityZhiming Mao, Jacob B Hirdler, Joanina K Gicobi, et al.
Journal for Immunotherapy of Cancer|October 28, 2025
Targeting PD-L1-CMTM6 interactions in myeloid cells triggers PD-L1 degradation and enhances cytotoxic T-cell expansionMichelle A Hsu, Xin Liu, Whitney Barham, et al.
Scientific Reports|June 17, 2015
Anchor-based classification and type-C inhibitors for tyrosine kinasesKai-Cheng Hsu, Tzu-Ying Sung, Chih-Ta Lin, et al.
Antimicrobial Agents and Chemotherapy|March 1, 1997
Pharmacokinetic enhancement of inhibitors of the human immunodeficiency virus protease by coadministration with ritonavirD J Kempf, K C Marsh, G Kumar, et al.
Plos One|November 13, 2024
Correction: Parallel Screening of Wild-Type and Drug-Resistant Targets for Anti-Resistance Neuraminidase InhibitorsKai-Cheng Hsu, Hui-Chen Hung, Jim-Tong Horng, et al.
Antimicrobial Agents and Chemotherapy|June 25, 2004
Inhibition of severe acute respiratory syndrome coronavirus replication by niclosamideChang-Jer Wu, Jia-Tsrong Jan, Chi-Min Chen, et al.
Pageof 37